A recent study has demonstrated the in vitro efficacy of DS-1594b as monotherapy or in combination with Venetoclax in KMT2A-r and NPM1-mutation cell lines, as well as in primary leukemia samples. The gene discussed is NPM1; the disease is leukemia.